Prescribing Information | JAKAFI® (ruxolitinib) Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it
Myelofibrosis (MF) Jakafi® (ruxolitinib) | Jakafi. com Find information about myelofibrosis (MF) and Jakafi® (ruxolitinib), the first FDA-approved prescription medicine for adults with intermediate or high-risk myelofibrosis
Polycythemia Vera Treatment - Jakafi Learn about Jakafi® (ruxolitinib), a prescription medicine used to treat adults with polycythemia vera (PV) who have already taken hydroxyurea and it did not work well enough or they could not tolerate it
Polycythemia Vera (PV) Jakafi® (ruxolitinib) | Jakafi. com Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it
What is Jakafi® (ruxolitinib)? Learn about Jakafi, a prescription medicine available as a pill Jakafi is used to treat adults with intermediate or high-risk myelofibrosis (MF)